Showing results (641-650 of 1,074) with videos related to
Sort By:
Pageof 108
Journal of Thrombosis and Thrombolysis|May 31, 2015
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trialsDominick J Angiolillo, Deepak L Bhatt, Ph Gabriel Steg, et al.Journal of the American College of Cardiology|September 18, 2020
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelDavide Capodanno, Marie-Claude Morice, Dominick J Angiolillo, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 10, 2024
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus documentPhilippe Garot, Marie-Claude Morice, Dominick J Angiolillo, et al.Revista Espanola De Cardiologia|November 28, 2006
[Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial]Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.Vascular Pharmacology|January 31, 2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromesWilliam A E Parker, Dominick J Angiolillo, Fabiana Rollini, et al.Circulation. Cardiovascular Interventions|May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyTracy Y Wang, Timothy D Henry, Mark B Effron, et al.Circulation. Cardiovascular Quality and Outcomes|December 12, 2019
Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility IndexMario Gaudino, Irbaz Hameed, Giuseppe Biondi-Zoccai, et al.Journal of the American College of Cardiology|March 26, 2016
Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Jenny Hu, et al.Journal of the American College of Cardiology|May 5, 2012
Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized studyAntonio Tello-Montoliu, Salvatore D Tomasello, José Luis Ferreiro, et al.Clinical Cardiology|December 12, 2024
Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study)Dhanunjaya Lakkireddy, Dominick J Angiolillo, Kristofer Charlton-Ouw, et al.Pageof 108